Il Dong Pharmaceutical Co Ltd (249420) — Capital Reinvestment Ratio
Il Dong Pharmaceutical Co Ltd (249420) has a Capital Reinvestment Ratio of 0.53x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩11.28 Billion) in capital expenditures (₩5.97 Billion). Check Il Dong Pharmaceutical Co Ltd (249420) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Il Dong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Il Dong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Il Dong Pharmaceutical Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for Il Dong Pharmaceutical Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Il Dong Pharmaceutical Co Ltd from 2016 to 2024. See Il Dong Pharmaceutical Co Ltd (249420) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.50x | ₩28.29 Billion | ₩14.05 Billion | ▼ -33.0% |
| 2020 | 0.74x | ₩19.37 Billion | ₩14.35 Billion | ▲ +154.2% |
| 2019 | 0.29x | ₩41.37 Billion | ₩12.06 Billion | ▲ +28.8% |
| 2018 | 0.23x | ₩66.65 Billion | ₩15.09 Billion | ▼ -0.2% |
| 2017 | 0.23x | ₩73.72 Billion | ₩16.73 Billion | ▼ -26.6% |
| 2016 | 0.31x | ₩45.98 Billion | ₩14.22 Billion | — |